🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main goal of this first-in-human (FIH) study is to learn about the safe...
Status
Recruiting
Location
Stanford Cancer Center
Start Date
2024-07-26
Trial ID
NCT06532565
Treatments Being Tested
Open-label, phase III, randomized, stratified (PDL1- vs PDL1+), 3 arms, mul...
Status
Recruiting
Location
Hospital General Universitario de Alicante
Start Date
2025-02-04
Trial ID
NCT06431633
Treatments Being Tested
A phase II study of peri-operative anti-PD1 (Zimberelimab) +/- anti-TIGIT (...
Status
Suspended
Location
Addenbrooke's Hospital
Start Date
2025-02-20
Trial ID
NCT06250036
Treatments Being Tested
The objective of this study is to evaluate the efficacy and safety of sacit...
Status
Recruiting
Location
The University of Arizona Cancer Center-North Campus
Start Date
2018-08-13
Trial ID
NCT03547973
This study is a single arm phase ll trial including 52 patients with T2N2-3...
Status
Unknown
Location
Sun Yat-sen University
Start Date
2023-12-01
Trial ID
NCT06107114
Treatments Being Tested
This is a phase 0/I exploratory study. Patients at first or second recurren...
Status
Active Not Recruiting
Location
University of California San Francisco
Start Date
2021-04-21
Trial ID
NCT04656535
Treatments Being Tested
This is a prospective, single arm, phase II clinical study on the treatment...
Status
Unknown
Location
Shanghai Zhongshan hospital
Start Date
2022-07-15
Trial ID
NCT05437692
Treatments Being Tested